Which closed-end funds own Arcus Biosciences Inc?
7 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $25.8M. Security type: common equity. Country: United States. CUSIP 03969F109 · ISIN US03969F1093 · ticker RCUS.
Holdings are historical filings (report dates May 29, 2026 – Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors | Healthcare | 0.69% | $4.8M | 155,060 sh | $690M | 3.5% discount | Jun 30, 2026 |
| THQ abrdn Healthcare Opportunities Fund | Healthcare | 0.61% | $6.4M | 207,838 sh | $1.1B | 7.7% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.55% | $6M | 194,015 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.51% | $7M | 226,769 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.28% | $1.6M | 51,616 sh | $573M | 3.7% discount | Jun 30, 2026 |
| GUG Guggenheim Active Allocation Fund | U.S. Equity | 0.00% | $13.3K | 526 sh | $631M | 14.1% discount | May 29, 2026 |
| QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund | Covered Call / Option Income | 0.00% | $24.8K | 803 sh | $1.6B | 3.8% discount | Jun 30, 2026 |
7 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: ARCUS BIOSCIENCES INC.
Issuer-level search for “RCUS” → · Compare two funds’ portfolios →